Risk factors for serious infections in ANCA-associated vasculitis
Article 2023 en
Authors
BO
Balazs Odler
RR
Regina Riedl
PG
Philipp Gauckler
Abstract
1 min read
The use of low-dose TMP/SMX is associated with reduced risk of severe infections in patients with AAV treated with either RTX or CYC/AZA. Reduced B cell subpopulations at start of treatment might be a useful correlate of reduced immunocompetence.
Zenas Z N Yiu, Christina Sorbe, Mark Lunt, Stephan Jeff Rustenbach, L Kühl, Matthias Augustin, K.J. Mason, Darren M. Ashcroft, Christopher Em Griffiths, Richard B. Warren
Wirongrong Chierakul, Siriluck Anunnatsiri, John M. Short, Bina Maharjan, Piroon Mootsikapun, Andrew J. H. Simpson, Direk Limmathurotsakul, Allen C. Cheng, Kasia Stepniewska, Paul N. Newton, Wipada Chaowagul, Sir Nicholas White, Sharon J. Peacock, N. P. Day, P. Chetchotisakd
Zenas Z N Yiu, Darren M. Ashcroft, Ian Evans, Kathleen McElhone, Mark Lunt, Catherine Smith, Shernaz Walton, Ruth Murphy, NJ Reynolds, A.D. Ormerod, Christopher Em Griffiths, Richard B. Warren
Discussion(0)
No comments yet. Be the first to comment.